CIS
ABBV icon

Continental Investors Services’s AbbVie ABBV Stock Holding History

Continental Investors Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$913K Buy
4,500
+1,785
+66% +$396K 0.86% 28
2025
Q4 		$606K Buy
2,715
+380
+16% +$86.6K 0.78% 38
2025
Q3 		$537K Buy
2,335
+8
+0.3% +$1.63K 0.8% 37
2025
Q2 		$432K Buy
2,327
+88
+4% +$16.4K 0.78% 38
2025
Q1 		$469K Buy
2,239
+112
+5% +$21.8K 0.93% 29
2024
Q4 		$378K Buy
2,127
+64
+3% +$11.8K 0.75% 39
2024
Q3 		$406K Buy
2,063
+30
+1% +$5.6K 0.83% 36
2024
Q2 		$349K Sell
2,033
-29
-1% -$4.8K 0.78% 40
2024
Q1 		$373K Buy
2,062
+106
+5% +$18.3K 0.88% 35
2023
Q4 		$303K Sell
1,956
-33
-2% -$4.81K 0.79% 35
2023
Q3 		$297K Sell
1,989
-1,968
-50% -$289K 0.9% 33
2023
Q2 		$563K Buy
3,957
+2,019
+104% +$296K 0.67% 34
2023
Q1 		$309K Sell
1,938
-14
-0.7% -$2.14K 0.87% 30
2022
Q4 		$315K Buy
1,952
+63
+3% +$9.66K 0.98% 26
2022
Q3 		$254K Buy
1,889
+1
+0.1% +$143 0.76% 32
2022
Q2 		$289K Buy
1,888
+47
+3% +$7.18K 0.84% 28
2022
Q1 		$249K Sell
1,841
-41
-2% -$5.96K 0.65% 39
2021
Q4 		$305K Buy
+1,882
New +$222K 0.81% 34

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Continental Investors Services's ABBV Position: Q1 2026 in Review

Continental Investors Services increased its AbbVie (ABBV) stake by 66% in Q1 2026, buying an estimated $396K and bringing the position to 4,500 shares worth $913K. The position accounts for 0.86% of the portfolio, ranked #28.

Continental Investors Services first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Continental Investors Services held 4,500 shares of AbbVie worth $913K as of Q1 2026.
  • Continental Investors Services bought 1,785 AbbVie shares in Q1 2026, an estimated $396K.
  • AbbVie made up 0.86% of Continental Investors Services's portfolio in Q1 2026, its #28 holding.
  • Continental Investors Services first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Continental Investors Services's 13F filing for Q1 2026, filed 15 May 2026.